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in the hope of preventing HIV transmission to their children. 
This study shows that the conditions required for safe formula 
feeding are present in Khayelitsha. 
The authors wish to acknowledge the women who participated 
in the study, the field workers and the personnel from the different 
clinics who made this study possible. 
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Percutaneous endoscopic gastrostomy in children 
a 5-year experience 
W G van der Merwe, R A Brown, J D Ireland, E Goddard 
Introduction. Percutaneous endoscopic gastrostomy (PEG) has 
been performed on children since 1979. The indications for a 
PEG are wide ranging and while there are well-established 
benefits, it remains a procedure with recognised 
complications. 
Goals and objectives. The goal of this study was to review our 
experience with this procedure at a South African paediatric 
tertiary referral hospital over a 5-year period. The objectiv€s 
were to review PEGs with regard to patient characteristics, 
indications, anaesthesia time required and complications. 
Methods. The study was a retrospective case record review. 
Results. A total of 70 PEGs were performed. Patients had a 
mean age of 4 years and 3 months, and a mean weight of 
12.2 kg at the time of performing the procedure. The mean 
anaesthetic time required for performing a PEG was 27 
The first percutaneous endoscopic gastrostomy (PEG) was 
performed by Michael Gauderer, a paediatric surgeon at the 
Cleveland University Hospital, in June 1979. The following 
year he and his co-workers1 reported on the first 12 cases in 
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minutes. Fifty-four PEGs (77%) were performed for inability 
to swallow, 15 (21 %) to improve caloric intake, and 1 (1 %) 
for continuous enteral feeding. There were no deaths, 5 
patients had major complications (6%), and 12 patients (17%) 
needed antireflux surgery subsequent to the placement of a 
PEG. 
Discussion. There is an increasing demand for PEGs at our 
institution. The indications for a PEG in this series are similar 
to those reported in other series, although we may be 
underutilising PEGs to improve caloric intake. Our 
complication rates compare favourably with those reported in 
other series. We have, however, identified post-PEG gastro-
oesophageal reflux disease as a complication we would like to 
reduce, and suggest a practical approach to do so. 
S Afr Med J 2003; 93: 781·785. 
children. The procedure was based on the novel concept of 
sutureless approximation of a hollow viscus to the abdominal 
wall. With clear advantages over conventional surgical 
gastrostomy (viz. no need for a laparotomy, short anaesthetic 
time or conscious sedation, and quicker postoperative 
recovery) the procedure has grown rapidly in popularity 
among both adult and paediatric clinicians. 
In the paediatric population PEG was initially most 
frequently used to assist in the feeding of neurologically 
impaired patients with dysphagia. In such cases PEG has 
established itself as an effective and convenient replacement for 
long-term nasogastric tube feeding with all its inherent 
fm 
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problems. Over time, however, the applications of PEG in 
clinical practice have expanded considerably and individual 
studies and reports have now documented the role of PEG in a 
wide variety of clinical settings. These include patients with 
burns,' cystic fibrosis,' congenital heart disease,5 cancer," 
chronic cholestasis,6 and AIDS.7 In broad terms the indications 
for a PEG are well delineated in a review by Kimber and 
Beasley' viz.: (i) inability to swallow; (ii) to improve caloric 
intake; (iii) administration of unpalatable feeds or medications; 
and (iv) administration of continuous enteral feeding. 
Goals and objectives 
At our institution PEGs have been performed since 1994, with 
an active PEG programme initiated in 1997 in a joint effort by 
the paediatric gastroenterology and paediatric surgical services. 
The goal of this study was to review our experience with this 
procedure over the first 5-year period since initiation of this 
endeavour. The objectives were to review PEGs with regard to 
patient characteristics, indications, anaesthetic time and 
complications. 
Methods 
This was a retrospective study. All case notes of patients who 
underwent PEG from June 1997 to June 2002 were reviewed. 
The setting was the Red Cross War Memorial Children's 
Hospital, a paediatric tertiary referral hospital in the Western 
Cape, South Africa. During this period PEGs were performed 
by two members of a trained team comprising two paediatric 
Table I. Clinical indications for a PEG (N = 70) 
gastroenterologists, a paediatric surgeon and a senior registrar 
in paediatric gastroenterology. The retrograde pull technique 
first described by Gauderer et a/.1 was used throughout, with 
the first member of the team performing a gastroscopy using a 
9 mm Olympus endoscope and the second member of the team 
performing the operative part of the procedure. The PEG size 
used varied from French 14 to French 20 depending on the size 
of the patient and the intended use of the PEG. 
Results 
A total of 70 PEGs were performed in the 5-year period and the 
number performed increased steadily over this period (Fig. 1). 
The mean age of patients at the time of PEG was 4 years and 3 
months (range: 1 month- 15 years and 1 month ). The mean 
weight was 12.2 kg (range: 2.2 - 45 kg ). Follow-up ranged from 
1 month to 5 years. All the procedures were performed under 
general anaesthesia and the mean anaesthetic time was 27 
minutes (range: 10- 60 minutes). Thirty of the procedures were 
performed during elective admission, with length of hospital 
stay ranging from 1 to 5 days. The remainder of the 
procedures were performed during a long stay in hospital for 
other reasons (defined as more than 10 days for the purposes 
of this study). 
The indications for PEG are summarised in Table I. In this 
study indications were considered to fall into one of three 
categories: (i) inability to feed or swallow (54 cases, 77%); (ii) 
to improve caloric intake (15 cases, 21 %); and (iii) 
administration of continuous enteral feeding (1 case, 1 %). In no 
case was administration of unpalatable medications or feeds 
Inability to feed/swallow Inability to feed/ 
Cerebral palsy 15 unpalatable medicines I feeds 
Neurological regression 2 Neurological regression/ seizures 2 
Syndromes 7 Syndrome with seizures 2 
Acute neurological damage Brain tumour I seizures 2 
Infective 6 Metabolic disorders 2 
Trauma/hypoxia 10 Immunodeficiency syndrome 1 
Muscular weakness 2 Syndrome with faecal loading 1 
Chronic tracheostomy 2 Total To (14%) 
Total 44 (63%) 
Improve caloric intake/ 
Improve caloric intake medicines I feeds 
Cystic fibrosis 4 Chronic renal failure 3 
Congenital heart disease 4 Fanconi syndrome/ cystinosis 
Chronic lung disease Nephrogenic diabetes insipidus 1 
HIV/AIPS 1 Total 5(7%) 
Total To (14%) 
Continuous enteral feeding 
Short bowel syndrome 1 
Total l(l%) 
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Fig. 1. Number of PEGs performed per year of study. 
considered to be the sole indication for a PEG, but where this 
was considered to form part of the indication this has been 
indicated as such in Table I. 
There was no mortality associated with the placement of a 
PEG during the 5-year study period. Five complications were 
considered to be major. Of these the most severe and life 
threatening was an oesophageal perforation resulting in a 
pneumomediastinum. This complication occurred while 
introducing a 9 mm gastroscope into the oesophagus of a 
2.3 kg baby. The patient made a full recovery with conservative 
management. A further 2 patients developed significant stomal 
complications requiring conversion to surgical gastrostomy. 
There was 1 case of submucosal migration of the internal PEG 
bumper, the so-called buried-bumper syndrome. This 
complication is illustrated in Fig. 2. Finally, 1 patient developed 
significant sepsis after placement of the PEG. 
Following the placement of a PEG 12 patients (17%) 
developed gastro-oesophageal reflux disease (GORD) which 
was considered severe enough to require antireflux surgery. 
When analysed retrospectively, 3 of these patients had no 
symptoms of gastro-oesophageal reflux before the placement of 
the PEG while 9 had symptoms of gastro-oesophageal reflux 
but the results of investigations for gastro-oesophageal reflux 
were either normal or not considered to be of adequate 
significance to exclude the placement of a PEG (2 patients 
demonstrated mild gastro-oesophageal reflux on a barium 
swallow, 4 patients had a normal barium swallow, 1 had a 
normal milk scan, 1 had a normal ultrasound of the gastro-
oesophageal junction while the final patient had normal 
barium, milk scan and pH studies.) 
Again when analysed retrospectively, 47 of the total of 70 
patients (67%) were asymptomatic for gastro-oesophageal 
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Fig. 2. Submucosal migration of internal bumper or buried-bumper 
syndrome. 
reflux before the placement of a PEG and 3 (6%) developed 
GORD requiring surgery. Twenty-three patients (33%) had been 
symptomatic for gastro-oesophageal reflux, and of these 9 
(39%) required antireflux surgery after the placement of a PEG. 
Of the 70 cases, 7 PEGs have been removed completely after 
re-establishing oral feeding, 32 have been changed for a skin-
level device or Foley catheter, and 18 remain in situ. Six of the 
PEGs were converted to a surgical gastrostomy (2 because of 
PEG stomal complications and 4 concomitant with antireflux 
surgery). Seven patients have died from causes unrelated to 
the procedure. 
Discussion 
There is increasing awareness of both the availability and 
indications for a PEG at our institution which is reflected in the 
steady increase in the number of procedures being performed. 
This is certainly in keeping with international experience. 
Matthewson et al.,' for example, report on the successful role of 
a multidisciplinary PEG advice team necessary to cope with 
the dramatically increased referral of patients to be considered 
for a PEG at their institution. 
In our series the majority of procedures have been performed 
for children with a neurological condition resulting in 
swallowing difficulty. This is in keeping with other reported 
paediatric series, although we are using PEGs to improve 
caloric intake less frequently than some groups (Table II). 10·" We ICr.!:ll 
need to strive to identify patients who can benefit from a PEG a:M 
in this clinical setting where its efficacy is well established'·' as 
well as in cases where it can be specifically used to administer 
unpalatable medications or feeds. 
We have shown that the anaesthetic time required for a PEG 
is relatively short and with increasing expertise it may become 
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Table II. PEG indications in paediatric series 
Inability to swallow (%) 
Improve caloric intake(%) 
Special medicines I feeds (%) 
Continuous enteral feeding{%) 
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Table III. Incidence of major complications and GORD requiring surgery in paediatric series 
Vander Merwe et al. Khattak et al." Marin et al.12 Gauderer et al." 
1991 2003 1998 1993 
N = 70 N = 120 N- 70 N=220 
Major complications(%) 





even shorter. We have had no experience in this series of 
performing the procedure under conscious sedation. Where the 
procedure was performed during an elective admission, 
hospital stay was generally short. These are advantages that 
one expects of a PEG over a surgical gastrostomy. 
Although PEG is now generally accepted as a safe and 
effective procedure, there is no doubt that it is associated with 
complications, both minor and major. In this series we focused 
only on major complications and our incidence rate of 6% was 
low when compared with that of other reported series in 
children10,1 2'13 (Table III). Certain of the frequently reported 
major complications have not been experienced by us at all. 
These include gastrocolic fi~tula formation, major haemorrhage 
and intestinal obstruction. We attribute this success to both 
good patient selection (i.e. no contraindications to the 
procedure) and attention to intraoperative techniques that 
prevent complications. Such strategies are very well described 
by Beasley et al.,l' and contraindications, although none are 
absolute, include previous upper abdominal surgery, 
abdominal organomegaly, presence of a ventriculoperitoneal 
shunt or peritoneal dialysis and small size of patient 
(particularly where a small gastroscope is not available). 
Although there are studies documenting the safety of PEGs in 
some of these scenarios (e.g. previous surgeri' or small sizel6), 
we believe it is important to assess all these factors in each 
individual case before making the decision to proceed with a 
PEG. 
The subject of gastro-oesophageal reflux in relation to PEG 
placement is a complex one and warrants individual attention. 
It remains unclear to what extent a PEG can influence pre-
existing gastro-oesophageal reflux and whether it can cause 





gastro-oesophageal reflux in a previously well patient. The 
number of CORD patients requiring surgery in this series was 
relatively high when compared with other paediatric series 
(Table III). The results of this series, however, suggest that the 
risk of a previously asymptomatic patient developing CORD is 
low. This finding is in keeping with the results of a study 
reported by Puntis et a/. 17 We have not had a formalised 
approach to investigation of patients symptomatic for gastro-
oesophageal reflux, but on the whole investigations performed 
were not useful in predicting which patients would develop 
CORD and this is certainly the experience of other authors.13 Of 
interest is that only 1 of our patients underwent a pH study, 
although the results of a study published by Sulaeman et aU' 
suggest that a pH study is a particularly useful investigation. 
In that study only 1% of patients who had a normal pH study 
developed CORD requiring surgery. In light of our findings 
and the available evidence in current literature on the subject, 
we propose a practical approach to PEG placement and gastro-
oesophageal reflux (Fig. 3). This is also proposed to form the 
basis of a prospective study to determine which patients will 
benefit at the outset from antireflux surgery and to reduce the 
incidence of CORD following the placement of a PEG. 
However, we do not expect this to be a foolproof strategy and a 
key aspect to the successful application of a PEG programme 
will continue to be careful follow-up by a team that should 
ideally also include a stomal therapist, dietitian and speech 
therapist. This is important not only with regard to gastro-
oesophageal reflux, but also the detection of minor and major 
complications (which may appear late), monitoring of optimal 
feeding and growth as well the timing of either removal or 
replacement of the PEG with an alternative feeding tube. 
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Good indication for a PEG 
+ 
No contraindications 
Asymptomatic for GOR Symptomatic for GOR/vomiting 
(consider a trial of NGT feeds) / ~ 
1 GOR disease · Barium/pH study 
No investigations+ / ~ l 
proceed with PEG / ---------------
~=-----~"G""~'' 
Careful follow-up 
NGT ~ nasogastric tube, COR = gastro-oesophageal reflux. 
Fig. 3. Suggested practical approach in assessing COR when 
considering a patient for a PEG. 
We acknowledge the excellent ongoing support provided for our 
patients by Sister. Monica Frank and her colleagues in the stomal 
therapy clinic and Mrs Dorothy van der Spuy and her colleagues in 
the dietetics department. 
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